New strategies on hypertension treatment.doc

 PAGE \* MERGEFORMAT 7 New strategies on hypertension treatment Residents in the 2002 National Nutrition and Health Survey found that the adult rate of 18.8% hypertension, high blood pressure in patients with an annual increase of 10 million, is expected by 2025, the proportion of people with hypertension worldwide will increase to 29%, reaching 1.56 billion . hypertension is the major hazards to human heart, brain, kidney and other target organ damage, high blood pressure treatment is the ultimate goal of minimizing the overall risk of cardiovascular and cerebrovascular disease. And the same year, China’s population of hypertension awareness, treatment and control rates are very low, most of the blood pressure control in hypertensive patients is not standard. meta-analysis showed that systolic blood pressure 10-12mmHg (1mmHg = 0.133kPa) or diastolic blood pressure decreased 5-6mmHg ,3-5 years, heart failure, stroke and cardiovascular disease mortality decreased by 52%, 38% and 21%, while coronary heart disease events decreased by only 16%. prospective study found that after treatment in the normal range of blood pressure control in hypertensive patients, the risk of coronary heart disease still significantly higher than the normotensive. epidemiologic data also showed that antihypertensive treatment failed to significantly reduce cardiovascular events in hypertensive patients. Lower blood pressure and cardiovascular risk anti-atherosclerosis relationship was confirmed by several studies. Simply can not bring satisfactory decompression in the treatment of coronary heart disease benefit, why not? Is well known that the main pathological basis of cardiovascular disease is atherosclerosis. Previous studies showed that atherosclerosis and hypertension are closely related, epidemiological studies have shown that 60% -70% of the coronary artery (coronary) atherosclerosis in patients with hypertension. And atherosclerosis in hypertensive patients have ve